Serving as Trusted Messengers about COVID-19 Vaccines and Therapeutics

Affiliations

¹ NMA 121(st) President, Professor of Family Medicine, The Ohio State University College of Medicine, Columbus, OH. Electronic address: Leon.McDougle@osumc.edu.
² Medical Director, Disease Control Division, Deputy Commissioner, Westchester County, Department of Health, NY.
³ Professor of Community Health & Preventive Medicine, Morehouse School of Medicine, Atlanta, GA.
⁴ General Internist, San Diego, CA.
⁵ Clinical Professor, Department of Pharmacy Practice, Southern Illinois University Edwardsville, Edwardsville, IL.
⁶ Family Physician, Los Angeles, CA.
⁷ Chief Medical Officer, Watts Healthcare Corporation, Los Angeles, CA.
⁸ Associate Professor of Medicine, Indiana University School of Medicine, Director, Marion County Public Health Department, Indianapolis, IN.
⁹ Professor and Chair, Department of Pediatrics, Division Chief, Allergy, Immunology, and Infectious Disease, Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ.

Editorial

Leon McDougle et al. J Natl Med Assoc. 2021 Feb.

. 2021 Feb;113(1):6-7.

doi: 10.1016/j.jnma.2021.01.003.

¹ NMA 121(st) President, Professor of Family Medicine, The Ohio State University College of Medicine, Columbus, OH. Electronic address: Leon.McDougle@osumc.edu.
² Medical Director, Disease Control Division, Deputy Commissioner, Westchester County, Department of Health, NY.
³ Professor of Community Health & Preventive Medicine, Morehouse School of Medicine, Atlanta, GA.
⁴ General Internist, San Diego, CA.
⁵ Clinical Professor, Department of Pharmacy Practice, Southern Illinois University Edwardsville, Edwardsville, IL.
⁶ Family Physician, Los Angeles, CA.
⁷ Chief Medical Officer, Watts Healthcare Corporation, Los Angeles, CA.
⁸ Associate Professor of Medicine, Indiana University School of Medicine, Director, Marion County Public Health Department, Indianapolis, IN.
⁹ Professor and Chair, Department of Pediatrics, Division Chief, Allergy, Immunology, and Infectious Disease, Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ.

No abstract available

References

1. Hamel L. Kaiser family foundation vaccine monitor: December 2020. 2020. https://www.kff.org/coronavirus-covid-19/report/kff-covid-19-vaccine-mon...
1. COVID-19 hospitalization and death by race/ethnicity. National center for immunization and respiratory diseases (NCIRD), division of viral diseases. 2020. https://www.cdc.gov/coronavirus/2019-ncov/covid-data/investigations-disc...
1. Interim clinical considerations for use of mRNA COVID-19 vaccines currently authorized in the United States. National center for immunization and respiratory diseases (NCIRD) 2020. https://www.cdc.gov/vaccines/covid-19/info-by-product/clinical-considera...
1. Interim considerations: preparing for the potential management of anaphylaxis after COVID-19 vaccination. National Center for Immunization and Respiratory Diseases (NCIRD) 2020. https://www.cdc.gov/vaccines/covid-19/info-by-product/pfizer/anaphylaxis...
1. Oliver S.E. The advisory committee on immunization practices' interim recommendation for use of pfizer-BioNTech COVID-19 vaccine — United States, December 2020. MMWR Morb Mortal Wkly Rep. 2020;69(50):1922–1924. https://www.cdc.gov/mmwr/volumes/69/wr/mm6950e2.htm?s_cid=mm6950e2_x - PMC - PubMed